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Background and purpose   In the last decade, intramedullary 
limb lengthening has become a viable alternative to traditional 
external systems. We retrospectively analyzed the use of an intra-
medullary motorized nail (Fitbone) in a consecutive series of 32 
patients.
Patients and methods   During the period September 2006 to 
December 2008, 32 consecutive patients with a median age of 17 
(IQR: 15–19) years were treated with a fully implantable, motor-
ized intramedullary lengthening device (Fitbone). The median leg 
length discrepancy was 35 (IQR: 30–44) mm at the femur (n = 21) 
and 28 (IQR: 25–30) mm at the tibia (n = 11). 
Results   Leg lengthening was successful in 30 of 32 cases, with 
no  residual  relevant  discrepancy  (±  5  mm).  No  intraoperative 
complications were observed. The consolidation index was signifi-
cantly different (p = 0.04) between femoral lengthening (mean 35 
days/cm) and tibial lengthening (mean 48 days/cm) but did not 
depend on age older/younger than 16 or previous operations at 
the affected site. 3 problems, 3 obstacles, and 4 complications (3 
minor, 1 major) were encountered in 8 patients, 5 of which were 
implant-associated. 
Interpretation      This  technique  even  allows  correction  in 
patients  with  multiplanar  deformities.  Compared  to  external 
devices, intramedullary systems provide comfort and reduce com-
plication rates, give improved cosmetic results, and lead to fast 
rehabilitation since percutaneous, transmuscular fixation is pre-
vented. This results in reasonable overall treatment costs despite 
the relatively high costs of implants.
 
Operative leg length equalization includes techniques such as 
contralateral epiphysiodesis during growth, or shortening and 
lengthening procedures. In the last decade, lower complica-
tion rates and greater patient comfort (Baumgart et al. 1997, 
Guichet 1999, Cole et al. 2001) have made intramedullary 
limb lengthening a valuable alternative to traditional exter-
nal fixation distractor systems (Guichet et al. 2003, Hanke-
meier et al. 2005, Leidinger et al. 2006, Krieg et al. 2008). 
Two mechanical devices, namely the Albizzia nail and the 
ISKD (intramedullary skeletal kinetic distractor) nail, and one 
motorized nail (Fitbone) have been reported (Betz et al. 1990, 
Cole et al. 2001, Guichet et al. 2003).
Here we present the indications and limitations, and the 
results and complications of the Fitbone nail. We identified 
possible factors that may influence the clinical outcome. In 
addition, we did a comparative cost analysis of different treat-
ment methods.
Patients and methods
During  the  period  September  2006  to  December  2008,  32 
consecutive patients with a median age of 16.9 (IQR: 15.3–
19.4) years were treated with a fully implantable, motorized 
intramedullary lengthening device (the Fitbone Sliding Active 
Actuator (SAA) nail and the Telescope Active Actuator (TAA) 
nail;  WITTENSTEIN  Intens  GmbH,  Igersheim,  Germany) 
(Figure 1). The median leg length discrepancy was 35 (IQR: 
30–44) mm at the femur and 28 (IQR: 25–30) mm at the tibia.
The underlying pathologies and the number of operations 
at the affected site are listed in Table 1. None of the cases 
Figure 1. Fitbone TAA (Telescope Active Actuator) and SAA (Sliding 
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Table 1. Patient characteristics and results
A  B  C  D  E  F  G  H  I  J  K  L  M  N  O 
  1  16.0  Femur  Posttraumatic  None   35  35  30  0.85  24  35  8  90    a 
  2  15.2  Tibia  Congenital  Ext, Vari   30  30  28  0.93  38  50  15    79 
  3  19.0  Tibia  Tumor  Flex, Vari  30  27  29  1.07  22  33  14    85 
  4  53.0  Femur  Congenital  Ext, Valg  45  45  60  1.33  20  35  14  86   
  5  15.9  Femur  Posttraumatic  Ext, Vari  30  25  22  0.88  18  31  14  89  87 
  6  15.2  Tibia  Posttraumatic  Valg  30  30  28  0.93  35  48  13    92  b
  7  15.0  Tibia  Congenital  Ext  25  25  27  1.08  36  49  14    86 
  8  15.7  Femur  Congenital  None  25  27  27  1  17  27  10  86   
  9  19.5  Femur  Tumour  Valg  40  40  35  0.87  19  29  10  89   
10  14.0  Femur  Posttraumatic  None  40  38  29  0.76  16  25  10  91   
11  34.5  Femur  Posttraumatic  None  40  38  32  0.84  16  27  12  92   
12  19.1  Femur  Congenital  Ext, IR  30  30  29  0.96  23  35  12  88    c
13  16.5  Femur  Tumor  Ext, IR  27  27  33  1.22  44  51  10  90   
14  19.3  Tibia  Congenital  Valg  28  31  35  1.12  77  133  14    86  d
15  14.4  Tibia  Congenital  Flex   25  26  27  1.04  40  65  7    88  e
16  15.3  Femur  Congenital  None  30  30  27  0.9  36  47  10  86   
17  16.8  Tibia  Congenital  Valg, ER  23  22  22  1  51  63  9    92 
18  17.5  Femur  Congenital  Vari, IR  45  42  48  1.14  16  29  12  89   
19  17.2  Femur  Posttraumatic  None  30  27  28  1.03  36  49  9  88   
20  16.3  Femur  Congenital  Vari  35  37  30  0.81  16  26  9  92   
21  15.3  Femur  Infection  Vari  60  60  87  1.45  25  27  10  86   
22  19.9  Femur  Posttraumatic  None  35  35  29  0.82  30  41  10  92   
23  14.4  Femur  Infection  Valg  80  80  82  1.02  26  27  14  102   
24  17.9  Tibia  Congenital  Vari  43  43  61  1.41  22  37  12    91  f
25  14.3  Femur  Congenital  Vari  55  55  51  0.93  30  41  14  86   
26  33.9  Tibia  Idiopathic  None  25  22  30  1.36  30  48  14    93 
27  11.5  Tibia  Infection  Valg, ER  51  54  49  0.9  13  24  12    86 
28  19.0  Tibia  Neurologic  Var  25  25  38  1.52  14  34  14    89  g
      (hemiparesis)
29  15.8  Femur  Congenital  Vari  40  40  34  0.85  17  20  11  90   
30  28.1  Femur  Congenital  Valg  25  20  29  1.45  30  54  15  87    h
31  19.1  Femur  Posttraumatic  IR  43  43  44  1.02  24  37  9  86   
32  18,8  Femur  Posttraumatic  None  24  21  35  1.66  37  62  9  88   
Mean    19.3        35.9  35.3  37.3  1.06  27    41.8  11.6  89.2  87.9 
Median 16.8        30  30.5  30  1.01  24  36.1  12.0  89.0  88.0 
A  Patient
B  Age
C Site 
D Diagnosis
E  Additional deformity correction
  Ext  extension
  ER  external rotation
  Flex  flexion 
  IR  internal rotation
  Valg  valgisation
  Vari  varisation
F  Target length, mm
G Length achieved, mm 
H Distraction period, days
I  Distraction index, mm/day
J  Maturation index, days/cm
K  Consolidation index, days/cm
L  Hospital stay, days
M Postop. mat. dist femur angle (LDFA), degrees
N Postop. med. proximal tibia angle (MPTA), degrees
O Complications
  a  Motor failure, device exchange
  b  Deep vein thrombosis
  c  Knee extension contracture
  d  Bolt loosening, running back 10 mm, insufficiant callus formation
  e  Bolt loosening, running back 5 mm
  f  Increase of pre-existing equinus deformity, delayed callus formation
  g  Bolt loosening
  h  Bolt loosening; running back 7 mm346  Acta Orthopaedica 2011; 82 (3): 344–350
had a history of osteomyelitis within the previous 2 years, nor 
showed any reduced bone quality. 9 patients presented with 
shortening as the only deformity, 14 presented with two defor-
mities, and 9 had three deformities.
The indication for surgery was based on a minimum LLD of 
more than 2 cm, clinical/functional symptoms, and ability to 
independently handle the lengthening device. Lengthening for 
cosmetic reasons only was not accepted. 
The  SAA,  which  is  restricted  to  femoral  use,  is  mostly 
implanted through an antegrade approach. As the SAA fea-
tures a slotted sliding hole in its middle part, this device allows 
lengthening as well as bone transport. TAA nails are available 
for both the femur and the tibia. They are implanted through a 
retrograde approach at the femur and an antegrade approach at 
the tibia. The femoral TAA is a straight nail; the tibial one is 
available as either a straight nail or one with a proximal Herzog 
angulation. In contrast to the SAA, lengthening with the TAA 
is accomplished by a telescoping mechanism. Various sizes, 
different designs, and even custom-made implants of both nail 
types are available.
Preoperatively, standardized anteroposterior and lateral long 
standing radiographs of both legs were taken and a preopera-
tive planning was performed, based on the protocol for ret-
rograde corrective planning described by Baumgart (2009). 
Mechanical axis alignment, LLD and projected joint angles, 
such as the mechanical lateral distal femoral angle (mLDFA, 
physiological  range  85–90°)  or  the  medial  proximal  tibial 
angle (MPTA, physiological range 85–90°), were documented 
pre- and postoperatively.
Percutaneous osteotomies were performed using a 4.0-mm 
drill and a chisel for completion, which causes minimal ther-
mal damage to the bone and preserves the periosteal sleeve, 
for optimal callus formation. 
Every patient received detailed oral and written instructions 
on the use of the device as well as an individual schedule with 
timing, rate, and total amount of lengthening. We aimed at 
starting distraction 5 days postoperatively at a distraction rate 
of 1.3 mm/day in femurs and starting 7 days postoperatively 
at 1.0 mm/day in tibias.
All patients were counseled regularly regarding the device 
and  were  followed  radiographically  on  a  biweekly  basis 
during and at 4-week intervals after distraction until full con-
solidation. The range of motion of hip, knee, and ankle joints 
was recorded in addition to pain (visual analog scale), wound 
status, and complications. All patients underwent an intensive 
rehabilitation program under the guidance of physiotherapists 
not any less frequently than twice a week, at least until con-
solidation.
Consolidation was defined as corticalization of at least 3 
sides of the callus on the biplane radiographs, with subsequent 
transition to full weight bearing. Insufficient callus forma-
tion was defined as a consolidation period more than 3 times 
longer than the distraction period (femur) or more than 4 times 
longer (tibia). 
Every  single  lengthening  period  (distraction,  maturation, 
consolidation)  and  the  appropriate  indices  (Figure  2)  were 
calculated and evaluated, with respect to the anatomical loca-
tion, previous operations at the affected site, and age older or 
younger than 16.
Leg lengthening was considered successful in cases with 
no residual relevant discrepancy of ± 5 mm. For deformity 
correction in the frontal plane, the mechanical axis deviation 
(MAD)  was  evaluated  preoperatively  and  intraoperatively 
with respect to the contralateral side and/or normal physiolog-
ical conditions (Paley et al. 1994). Intraoperatively, mechani-
cal axis alignment was determined by use of a grid plate with 
radio-opaque  straight  lines,  which  was  placed  underneath 
the patient on a radiolucent table. The Paley outcome score 
system designed for femora was used (Paley et al. 1997) and a 
modified version introduced by Krieg et al. (Krieg et al. 2008) 
was used for tibias. 
Complications were differentiated as problems (grade 1), 
obstacles (grade 2), and minor or major complications (grade 
3) (Paley 1990).
The calculation of total costs for a Fitbone treatment was 
based on the current local reimbursement rates for a public 
patient,  1  segment  affected,  implantation  and  explantation, 
hospital stay of 3 weeks in total (implantation and explanta-
tion), and physiotherapy twice a week for 1 year. Likewise, 
overall costs for leg length equalization by means of orthotic 
devices  were  calculated  by  a  local  orthopedic  technician 
assuming a non-private patient with a leg length discrepancy 
of more than 2 cm requiring shoe lifts and necessary addi-
tional insoles twice a year for 60 years. In addition, implant 
costs for the Taylor Spatial Frame were taken from the manu-
facturer’s price list.
The median follow-up time was 16 months (IQR: 12–22; 
range 12–27 months). By the end of the observation period, 
all but 2 nails had been explanted after a median of 14 months 
(IQR: 13–17; range 6.6–23 months).
Statistics
Data are  given  as  means, medians,  and interquartile range 
Figure 2. Overview of the different indices. 
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(IQR). Comparisons between patient subgroups were assessed 
using Fisher’s exact test for binary endpoints and by the Mann-
Whitney U-test for continuous endpoints. A p-value of ≤ 0.05 
was taken to indicate statistical significance. Statistical analy-
sis was performed using SPSS software version 17.0.
Results 
Length gain
Leg length equalization was successful in 30 of 32 cases (± 
5mm). 2 showed a remaining LLD of 7 mm and 10 mm, which 
was clinically irrelevant. At the femur, the target length was 
achieved with a standard deviation of ± 6.1%. Regarding the 
tibia, the equalization was accomplished with a standard devi-
ation of ± 7.3%.
Distraction index and hospital stay
Distraction was started at an average of 6 (3–12) days postop-
eratively with a median distraction index of 1.0 (IQR: 0.9–1.2) 
mm/day and a median distraction period of 30 (IQR: 28–42) 
days. The median hospital stay was 12 (IQR: 10–14) days.
Maturation
There was no statistically significant difference in the matura-
tion index in terms of the influencing variables examined.
The median maturation period was 75 (IQR: 60–106) days 
for femurs (n = 21) and 96 days (IQR: 66–112) for tibias (n = 
11).  The  median  maturation  index  was  22  days/cm  (IQR: 
16–30) for femurs and 36 (IQR: 22–40) days/cm for tibias.
Consolidation
The median consolidation index was 35 (IQR: 27–44) days/
cm for the femur and 48 (IQR: 34–63) days/cm for the tibia. 
A statistically significant difference between femurs and tibias 
was seen, but not regarding other influencing variables. 
Deformity corrections
The median preoperative mechanical axis deviation (MAD) in 
patients with a varus axis (n = 8) was 13 (6–50) mm medially 
to the center of the knee joint, whereas the median postopera-
tive MAD was 4 mm medially (38 mm medially to 11 mm 
laterally). In patients with a valgus axis (n = 9), the median 
preoperative MAD was 13 (5–54) mm laterally as compared 
to a postoperative median of 0 mm (10 mm medially to 28 mm 
laterally). 
In patients with additional rotatory and/or sagittal correc-
tive osteotomies (n = 5), a bilaterally equal range of motion of 
the hip and knee joint was seen immediately postoperatively 
(Table 1).
Joint motion
The functional outcome was excellent in 26 patients, good in 
5, and fair in 1. All but one had regained or even improved 
upon their preoperative range of motion of the hip, knee, and 
ankle joint (n = 8) (Figure 3).
Complications
No intraoperative complications and no postoperative bone 
or soft tissue infections occurred. We observed 3 problems, 3 
obstacles, and 4 complications (3 minor, 1 major) in 8 patients 
(Table 1). Insufficient callus formation was found in 2 tibias 
of smokers who both refused weight bearing. One (patient 14) 
was treated with autologous tricortical iliac bone grafting 8 
months postoperatively. The other showed slow consolidation 
without need of further operative intervention. 
In 1 case with a history of lengthening by external fixa-
tion  (patient  12),  a  progressive  knee  extension-contracture 
required manual mobilization under anesthesia 5 months after 
the end of distraction.
One motor stopped because of overstraining of the mechani-
cal implant by full weight bearing early on the patient’s own 
authority, during the initial distraction period and after dis-
charge from the hospital. It had to be exchanged, but this did 
not affect the final result. In 3 cases we observed running back 
of the telescopic part of the nail during the initial consolida-
tion  phase,  which  was  twice  associated  with  loosening  of 
locking bolts. Another bolt loosened without loss of length. 
The persisting equinus of the foot in 1 patient (patient 24) 
was successfully corrected by a combined calcaneus and talus 
osteotomy using the Taylor Spatial frame.
Costs
Total costs of approximately 100,000 euros were calculated to 
equalize a leg length discrepancy of more than 2 cm by means 
of orthotic devices. For a Fitbone treatment, total costs of 
approximately 38,000 euros were calculated (see Patients and 
methods). Pure implant costs amount to approximately 11,000 
euros for the Fitbone nail, and to 7,500 euros for a standard 
Taylor Spatial Frame.
Figure 3. Range of motion 4 months post-
operatively, after 5.5 cm of lengthening of 
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Discussion
The  use  of  mechanically  driven  intramedullary  nails  for 
limb lengthening and deformity correction has been reported 
repeatedly (Baumgart et al. 1997, Cole et al. 2001, Guichet 
1999, Hankemeier et al. 2005, Guichet et al. 2003, Leidinger 
et al. 2006, Krieg et al. 2008, Betz et al. 1990, Garcia-Cim-
brelo et al. 2002, Singh et al. 2006, Baumgart et al. 2006). 
The ISKD and the Albizzia are mechanically driven nails and 
provide all the advantages of intramedullary leg lengthening 
(Cole et al. 2001). Distraction with the ISKD is achieved by 
physiological gait movements. Thus, the distraction rate is less 
predictable, which may contribute to insufficient callus forma-
tion (Leidinger et al. 2006). In contrast, the Albizzia some-
times causes severe pain and discomfort at the osteotomy site 
since lengthening is accomplished by rotational maneuvers. 
Some authors have even reported re-admission for distraction 
under anesthesia (Garcia-Cimbrelo et al. 2002, Guichet et al. 
2003). The Fitbone nail is the only intramedullary motorized 
lengthening device. In order to avoid high complication rates, 
the distribution was limited to a small number of selected sur-
geons by the company during the thorough implant develop-
ment process. 
Since  most  peer-reviewed  literature  on  intramedullary 
lengthening involves a small number of patients (Table 2), we 
considered that it would be useful to add this relatively large 
case series.
Unlike the application of external fixators, a solid intramed-
ullary device requires defined anatomical preconditions that 
have to be adhered to, both during the preoperative planning 
and intraoperatively. However, for the accomplishment of cor-
rections in 3 dimensions, reaming of the intramedullary cavity 
with straight and rigid reamers (not flexible ones) is as a pre-
requisite. Only the use of rigid reamers, which do not follow 
the line of minor resistance, allows to carry out the correlations 
anticipated during preoperative planning. In this context, ade-
quate medullar dimensions respecting a minimal nail diameter 
of 11 mm at its shaft are one of the most important limitations 
of the Fitbone TAA. Further restrictions derive from its short 
overall length and a mandatory osteotomy level 7–11 cm from 
the joint line to ensure stable interlocking conditions. Marked 
angular deformities and a center of rotation and angulation far 
from the planned osteotomy are additional geometric obsta-
cles, and may make segmental translation unavoidable (Figure 
4). Axis  alignment  or  implant  position  cannot  be  changed 
postoperatively.  Hence,  intraoperative  acknowledgment  of 
the preoperative planning is important (Baumgart 2009). In 
contrast, external fixators—and particularly the Taylor Spatial 
Frame (TSF)—are more forgiving by allowing postoperative 
and even computer-assisted adjustments (Blondel et al. 2009). 
However, even complex deformities may be overcome (Figure 
5).
Application of solid lengthening nails in children is limited 
by open growth plates. However, data on children treated for 
tumors and also unpublished observations of experienced sur-
geons (regarding limb lengthening) suggest that the growth 
potential  may  remain  unaffected  when  smooth  polished 
implants are inserted through the central portion of a physis 
(Neel et al. 2004, Baumgart et al. 2006).
In keeping with the results of Fischgrund et al. (1994), we 
found a statistically significant difference in the consolidation 
index of patients with femoral lengthening and of those with 
tibial lengthening. However, as additional consideration of the 
maturation index did not reveal any statistically significant 
disparity, this may rather be explained by an earlier distrac-
tion start and higher daily rates at the femur. It is our experi-
ence that a distraction rate of about 1.3 mm/day at the femur is 
well accepted and sometimes even required in children, due to 
the enormous regeneration potential. This might be due to the 
excellent soft tissue coverage and the gentle osteotomy tech-
Table 2. Summary of case series in peer-reviewed literature
Author  Device  No. of cases
Baumgart et al. 2005  motorized nail  12
Cole et al. 2001  mechanical nail  18
Hankemeier et al. 2005  mechanical nail    4
Guichet et al. 2003  mechanical nail  31
Leidinger et al. 2006  mechanical nail  22
Krieg et al. 2008  motorized nail    8
Betz et al. 1990  motorized nail    3
Garcia-Cimbrelo et al. 2002  mechanical nail  23
Singh et al. 2006  motorized nail  10
Figure 4. Frontal plane double deformity of the tibia with LLD of 5.5 
cm in a patient with a history of osteomyelitis in early childhood and of 
previous operations.
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nique, which further contribute to rapid bone formation and 
consolidation.
Without transfixation of skin and muscles, lengthening nails 
facilitate full joint motion in the first few days after surgery, 
whereas external fixators decrease the range of motion even 
before  the  lengthening  process  has  started  (Maffulli  et  al. 
2001). Thus, re-establishment of full range of motion with 
external  fixators  mostly  exceeds  rehabilitation  times  with 
intramedullary devices by far, as seen in our study.
The complication rates of external fixators range from 24% 
to 117% (Paley 1990, Tjernstrom et al. 1994, Paley et al. 1997, 
Blondel et al. 2009) and from 11% to 47% (Cole et al. 2001, 
Garcia-Cimbrelo et al. 2002, Guichet et al. 2003, Leidinger 
et al. 2006) for mechanically driven intramedullary devices, 
depending on the distraction length and the experience of the 
surgeon.
A complication rate of 12.5% in our series (4 of 32 patients) 
is in keeping with the findings of Baumgart et al. (2006) who 
reported a 13% complication rate in a larger number of patients 
(n = 150) treated with Fitbone TAA and SAA nails. These low 
complication  rates  may  be  attributed  to  the  electronically-
actuated lengthening mechanism and its reliable controllabil-
ity—with consistent distraction rates as a consequence. 
Technical complications or implant breakage rarely occur 
with Fitbone. In the series of 150 patients, Baumgart et al. 
(2005)  reported  technical  difficulties  in  6%  of  cases  and 
implant  breakage  in  5%,  with  only  a  3%  rate  of  implant 
exchanges in total. Partial loss of gained length, as seen in 3 
of our 32 patients, may occur due to loosened locking bolts or 
running back of the telescoping part. The latter will presum-
ably be prevented now with the new generation of nails that 
have a running-back barrier.
The overall cost of lengthening with Fitbone was less than 
for  conservative  treatment,  assuming  the  conditions  men-
tioned earlier. Compared to external fixators such as the Taylor 
Spatial Frame, the Fitbone nail is somewhat more expensive. 
However, the much higher complication rate of external fixa-
tion—probably  associated  with  additional  hospital  stays, 
medication (pain relief, antibiotics), and physiotherapy ses-
sions—warrant  differentiation  between  pure  implant  costs 
and costs of treatment, in addition to “soft” factors such as 
cosmetics, patient satisfaction, and quality of life during and 
after the lengthening procedure (Tjernstrom et al. 1994, Paley 
1990, Song et al. 2005). 
Paley et al. (1997), who published a similar cost report, put 
forward mean costs of about $24,000 ($18,000 to $28,000) 
for  unilateral  femoral  lengthening  over  an  intramedullary 
nail compared to $19,000 ($18,000 to $29,000) for unilateral 
Ilizarov femoral lengthening. Likewise, they included hospital 
charges as well as fees for the index procedure and removal of 
the external fixator (factors such as duration of hospital stay 
were not listed in detail) but did not include the costs for reha-
bilitation and additional costs due to complications. Even so, 
these considerations should be taken into account in order to 
compare overall costs. Healthcare providers especially—who 
tend to refuse reimbursement of new and at first sight expen-
sive innovative methods—should be made to understand that 
such treatment options may prove to be less expensive if the 
wider picture of overall cost is taken into account.
Apart from the explicit desire of the majority of our patients 
to have the implants removed after the lengthening procedure, 
we consider the removal mandatory in order to avoid difficul-
ties in the future, such as removal of an ingrown nail or inter-
ference with arthroplastic devices later on. Furthermore, the 
analysis of each explanted device by the manufacturer contrib-
utes to the quality of management and promotes development 
and perfection of the nail.
Our study was limited by the lack of a matched control 
group,  treated  with  different  lengthening  devices.  Further-
more, long-term results on lengthening with Fitbone nails are 
still not available. 
In  summary,  the  outcome  achieved  in  our  patients  is  a 
respectable  result,  and  there  was  a  low  complication  rate. 
There was a significant difference in the consolidation index 
in the treatment of femurs and tibias. The high implant costs 
are compensated for by competitive treatment costs. Intramed-
ullary leg lengthening is, however, a demanding procedure. 
AHK and CCH planned the study and BMS analyzed the data. AHK and UL 
wrote the first draft of the manuscript. AHK, UL, BMS, and CCH contributed 
to interpretation of the results and revised the manuscript. 
No external funding was received for this study from the manufacturer or 
other sources. There are no competing interests.
Figure 5. Anteroposterior and lateral radiographs 3 months (left) and 9 
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